The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zakharov S.M.

Moscow Regional Research Institute of Obstetrics and Gynecology, Moscow, Russia

Chechneva M.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Budykina T.S.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Hypercoagulable states and pregnancy

Authors:

Zakharov S.M., Chechneva M.A., Budykina T.S.

More about the authors

Read: 6334 times


To cite this article:

Zakharov SM, Chechneva MA, Budykina TS. Hypercoagulable states and pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(1):33‑37. (In Russ.)
https://doi.org/10.17116/rosakush20191901133

Recommended articles:
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151

References:

  1. Barkagan ZS, Momot AP. Classification and basics of diagnosis of hematogenic thrombophilia. Klinicheskaya laboratornaya diagnostika. 1999;10:38. (In Russ.)
  2. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-530.
  3. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370-1373.
  4. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984;64:1297-1300.
  5. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci. 1993;90:1004-1008.
  6. Belousova TV, Marinkin IO, Plyushkin VA, Leonova AA. Interconnections in the mother—placenta—child system in the state of thrombotic readiness and hematogenous thrombophilia. Byulleten’ sibirskoi meditsiny. 2016;15:5:5-15. (In Russ.) https://doi.org/10.20538/1682-0363-2016-5-5-15
  7. Bokarev IN, Popova LV. What is thrombophilia today? Klinicheskaya meditsina. 2013;12:4-9. (In Russ.)
  8. Murphy MM, Fernandez-Ballart JD. Homocysteine in pregnancy. Adv Clin Chem. 2011;53:105-137.
  9. Momot AP. Evolution of ideas about thrombophilia and its role in human pathology. Problemy klinicheskoi meditsiny. 2012;1-4:10-15. (In Russ.)
  10. Ignat’eva NS, Veisgeim VM, Evseeva VA, Timoshenskaya NV, Suvorova AV. Early diagnosis of thrombosis in newborns. Pediatria. 2010;89:1:41-43. (In Russ.)
  11. Eso Y, Yoshiji S, Nakakubo Y, Matsuura M, Seno H. Acute Anorectal Thrombophlebitis Caused by a Protein C Deficiency. Intern Med. 2018; 57:2:209-212. https://doi.org/10.2169/internalmedicine.9131-17
  12. Gomellya MV. Thrombophilia in children. Zdorov’e cheloveka. 2008;1:312-324. (In Russ.)
  13. Bitsadze VO, Makatsariya A, Khizroeva DKh, Makatsariya NA, Yashenina EV. Thrombophilia as the most important link in the pathogenesis of pregnancy complications. Prakticheskaya meditsina. 2012;5:22-29. (In Russ.)
  14. Nowak-Gotti U, Duering C, Kempf-Bielack B, Sträter R. Thromboembolic Diseases in neonates and children. Haemost Thromb. 2004;33:269-274.
  15. Rukavitsyna OA. Hematology. National Guidance. Moscow: GEOTAR-Media, 2017;240. (In Russ.)
  16. Park L, Kim JH. A novel approach for identifying causal models of complex diseases from family data. Genetics. 2015;199:4:1007-1016. https://doi.org/10.1534/genetics.114.174102
  17. Bokarev IN, Popova LV. Modern views of thrombophilia. Klinicheskiy opyt dvadtsatki. 2013;2:7-15. (In Russ.)
  18. Moheimani F, Jackson DE. Venous thromboembolism: Classification, risk factors, diagnosis and management. ISRN Hematol. 2011;2011:124610. https://doi.org/10.5402/2011/124610
  19. Taheraghdam AA, Dalirakbari N, Khalili M, Soltani M, Ahari SS. Hyperhomocysteinemia, low vitamin B12, and low folic acid: Are risk factors of cerebral vascular thrombosis in northwest Iran? J Res Med Sci. 2016;21:16.
  20. Makatsariya AD, Bitsadze VO, Khizroeva DKh. Catastrophic antiphospholipid syndrome in obstetrical practice. Zhurnal akusherstva i zhenskikh boleznei. 2012;61:3:7-21. (In Russ.) https://doi.org/10.17816/jowd6137-21
  21. Kang SS, Rosenson RS. Analytic approaches for the treatment of hyperhomocysteinemia and its impact on vascular disease. Cardiovasc Drugs Ther. 2018;32:2:233-240.
  22. Kumar A, Misra S, Sagar R, Kumar P, Yadav AK, Talwar P, Raj R, Prasad K. Relationship between factor V Leiden gene variant and risk of ischemic stroke: A Case-Control Study. Ann Indian Acad Neurol. 2017;20:3:284-288. https://doi.org/10.4103/aian.AIAN_31_17
  23. Barbosa PR, Stabler SP, Machado AL, Braga RC, Hirata RD, Hirata MH, Sampaio-Neto LF, Allen RH, Guerra-Shinohara EM. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr. 2008;62:8:1010-1021. https://doi.org/10.1038/sj.ejcn.1602810
  24. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:1:6-15. https://doi.org/10.1093/eurheartj/ehn515
  25. Petrikov AS, Shoikhet YaN, Belykh VI, Kostuchenko GI, Kotovschikova EF, Peregudova IG. Hyperhomocysteinemia — risk factor for deep vein thrombosis. Meditsina i obrazovanie v Sibiri. 2011;4:4. (In Russ.)
  26. Makatsaria AD. Thrombohemorrhagic complications in obstetric-gynecological practice. Moscow. 2011;91-110. (In Russ.)
  27. Klepikova AA, Zolotykh OS, Evseeva ZP, Ashrova TE, Kachantseva TA, Sagamonova KYu. Thrombophilia and pregnancy outcomes. Kazanskii meditsinskii zhurnal. 2011;92:6:846-850. (In Russ.)
  28. Momot AP, Nikolaeva MG. Thrombophilia in obstetric-gynecological practice. Heparin prophylaxis. Meditsinskii sovet. 2017;13:71-78. (In Russ.)
  29. Burton GJ, Charnock-Jones DS, Jauniaux E. Regulation of vascular growth and function in the human placenta. Reproduction. 2009;138:895-902. https://doi.org/10.1530/REP-09-0092
  30. Kaneva FM, Frolov AL, Akhmetova VG, Khusnutdinova EK, Gilmanov AZh. Peculiarities of hemostasis in women with miscarriage. Klinicheskaya laboratornaya diagnostika. 2012;8:37-43. (In Russ.)
  31. Trifonova EA, Gabidulina TV, Agarkova TA, Serebrova VN, Butko UK, Vorozhischeva AU, Yuriev SU, Devyatiarova LA, Minaicheva LI. Analyzing the role of inherited thrombophilia in the development of complicated pregnancy. Fundamentalnye issledovaniya. 2012;10:2:337-344. (In Russ.)
  32. Agnieszka Paradowska-Gorycka, Andrzej Pawlik, Romanowska-Prochnicka K, Haladyj E, Malinowski D, Stypinska B, Manczak M, Olesinska M. Relationship between VEGF gene polymorphisms and serum VEGF protein levels in patients with rheumatoid arthritis. PLoS One. 2016;11:8:e0160769. https://doi.org/10.1371/journal.pone.0160769
  33. Louise E. Simcox, Laura Ormesher, Clare Tower, Ian A. Greer Philip Newton Baker, Academic Editor. Thrombophilia and pregnancy complications. Int J Mol Sci. 2015;16:12:28418-28428. https://doi.org/10.3390/ijms161226104
  34. Baimuradova SM, Slukhanchuk EV. Methodological manuals to help the practitioner. Moscow. 2018;4-6. (In Russ.)
  35. Di Prima FA, Valenti O, Hyseni E, Giorgio E, Faraci M, Renda E, De Domenico R, Monte S. Antiphospholipid syndrome during pregnancy: The state of the art. J Prenat Med. 2011;5:41-53.
  36. Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: ‘extra-criteria’ manifestations and technical advances. Nat Rev Rheumatol. 2017;13:9:548-560.
  37. Lázaro I, Carmona F, Reverter JC, Cervera R, Tassies D, Balasch J. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies. Am J Obstet Gynecol. 2009;201:1:87.e1-e6. https://doi.org/10.1016/j.ajog.2009.03.014
  38. Khromylev AV, Makatsariya AD. Pathogenetic mechanisms of the thromboembolic complications of the metabolic syndrome in pregnant women. Rossiiskii meditsinskii zhurnal. 2014;8: 1:68-73. (In Russ.)
  39. Agadzhanova AA. Modern methods of treatment of patients with recurrent miscarriage. Russkii meditsinskii zhurnal. 2003;11:1:3-6. (In Russ.)
  40. Makatsariya AD, Bitsadze VO, Akinshina SV. Pharmacotherapy in obstetrics and gynecology. The use of low molecular weight heparin in obstetric, gynecological and oncological practice. Consilium medicum. 2005;7:7:556-565. (In Russ.)
  41. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-474. https://doi.org/10.2147/VHRM.S20181
  42. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38:2 Suppl:S26-34. https://doi.org/10.1097/CCM.0b013e3181c98d21
  43. Lazareva GA, Khuraseva AB, Klycheva OI. Modern view on the problem of placental insufficiency. Nauchnye vedomosti BelGU. Seria: Meditsina. Farmatsia. 2014;27:18(189):5-10. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.